JNJ-17203212
| Title | Journal |
|---|---|
| Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. | Thorax 20121001 |
| TRPV3 and TRPV4 ion channels are not major contributors to mouse heat sensation. | Molecular pain 20110101 |
| Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. | Bioorganic & medicinal chemistry letters 20101201 |
| A novel TRPV1 receptor antagonist JNJ-17203212 attenuates colonic hypersensitivity in rats. | Methods and findings in experimental and clinical pharmacology 20101001 |
| Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder. | The Journal of urology 20090801 |
| Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20081217 |
| Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs. | The Journal of pharmacology and experimental therapeutics 20071101 |
| The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain. | Journal of medicinal chemistry 20070531 |
| Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. | Journal of medicinal chemistry 20050324 |